Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Microcap & Penny Stocks : TGL WHAAAAAAAT! Alerts, thoughts, discussion. -- Ignore unavailable to you. Want to Upgrade?

To: Taki who wrote (131951)	4/27/2004 12:13:07 PM
From: Taki	Respond to of 150070

HTDS.021.I am in:Due to this out today:The move is brilliant, HTDS’s management, in our opinion, must have good news coming on their drug Tubercin® and we will monitor HTDS daily and keep our readers informed on all fronts. This decision by HTDS seems to be a practical one in that it brings cash to the company and it allows HTDS to concentrate on the drug, Tubercin®. Currently, HTDS was trying to manage to important divisions which are worlds apart from each other. The move is brilliant, HTDS’s management, in our opinion, must have good news coming on their drug Tubercin® and we will monitor HTDS daily and keep our readers informed on all fronts. HTDS announced yesterday, April 26th, 2004, that the Company has signed a letter of intent to sell the assets of its recycling division, International Foam Solutions. HTDS will sell the recycling assets of its International Foam Solutions Division for $250,000 and 20% of the stock of the purchasing company. The sale should be finalized within 30 days in accordance with the letter of intent. The purchasing company has patent technology which is more encompassing than the patent technology being sold by HTDS. This decision by HTDS seems to be a practical one in that it brings cash to the company and it allows HTDS to concentrate on the drug, Tubercin®. Currently, HTDS was trying to manage to important divisions which are worlds apart from each other. The move is brilliant, HTDS’s management, in our opinion, must have good news coming on their drug Tubercin® and we will monitor HTDS daily and keep our readers informed on all fronts.